Strategic Growth Pinnacle Clinical Research is expanding its national footprint, highlighted by the acquisition of Jubilee Clinical Research, which signals ongoing capacity-building opportunities for sponsor and CRO partnerships seeking broader site access and diverse patient populations.

Therapeutic Focus With demonstrated expertise in liver disease, metabolic disorders, memory loss, and neurodegenerative conditions, there are clear cross-sell opportunities to sponsors targeting these high-need therapeutic areas who require experienced, patient-centric site networks.

Operational Excellence The company emphasizes rapid enrollment, reliable data, and strong retention, presenting a value proposition to sponsors and trial managers seeking efficient timelines and high-quality trial conduct across complex protocols.

Partnership Readiness Existing collaborations with sponsors, CROs, and healthcare providers, plus a growing national footprint, position Pinnacle as a turnkey partner for multi-site studies, complex enrollment strategies, and global or multi-regional trials.

Market Position Revenue indicators in the mid-cap range and an active growth story place Pinnacle as a compelling mid-tier alternative to larger CROs for mid-to-large phase trials, enabling personalization, patient engagement, and faster time-to-market.